Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru
Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru
About this item
Full title
Author / Creator
Publisher
Netherlands: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Netherlands: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Highlights • Pneumococcal conjugate vaccines (PCV) help to prevent pneumococcal diseases (PD). • PCV13 reduces more cases of severe PD, deaths and sequelae than PCV10. • PCV10 prevents more AOM cases than PCV13. • Separately, both PCV13 and PCV10 showed to be cost-effective in Peru. • Overall, PCV13 is more cost-effective than PCV10 for the Peruvia...
Alternative Titles
Full title
Cost-effectiveness analysis of 10- and 13-valent pneumococcal conjugate vaccines in Peru
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1717493657
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1717493657
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2014.12.039
